Individualized correction of neuron-specific enolase (NSE) measurement in hemolyzed serum samples

Clinica Chimica Acta

Volumn 424, Issue , 2013, Pages 216-221

  Tolan, Nicole V ^a   Vidal Folch, Noemi ^a   Algeciras Schimnich, Alicia ^a   Singh, Ravinder J ^a   Grebe, Stefan K G ^a  

^a MAYO CLINIC   (United States)

Author keywords

Individualized hemolysis correction; Ischemic brain injury; Neurological prognosis; Neuron specific enolase; Therapeutic hypothermia

Indexed keywords

HEMOGLOBIN; NEURON SPECIFIC ENOLASE;

ACCURACY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; ENZYME ACTIVITY; ENZYME STRUCTURE, FUNCTION AND VARIABILITY; HEMOLYSIS; HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; QUORUM SENSING; STATISTICAL ANALYSIS;

INDIVIDUALIZED HEMOLYSIS CORRECTION; ISCHEMIC BRAIN INJURY; NEUROLOGICAL PROGNOSIS; NEURON-SPECIFIC ENOLASE; THERAPEUTIC HYPOTHERMIA;

ERYTHROCYTES; HEMOGLOBINS; HEMOLYSIS; HUMANS; ISOENZYMES; PHOSPHOPYRUVATE HYDRATASE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84880374237     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.06.009     Document Type: Article

References (38)

1. Wold F., Ballou C.E. Studies on the enzyme enolase. J Biol Chem 1957, 227:313-328.
2. Aksamit A.J., Preissner C.M., Homburger H.A. Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease. Neurology 2001, 57:728-730.
3. Green A.J., Thompson E.J., Stewart G.E., et al. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2001, 70:744-748.
4. Sanchez-Juan P., Green A., Ladogana A., et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2006, 67:637-643.
5. Bahl J.M., Heegaard N.H., Falkenhorst G., et al. The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease. Neurobiol Aging 2009, 30:1834-1841.
6. Berger R.P. The use of serum biomarkers to predict outcome after traumatic brain injury in adults and children. J Head Trauma Rehabil 2006, 21:315-333.
7. Guzel A., Er U., Tatli M., et al. Serum neuron-specific enolase as a predictor of short-term outcome and its correlation with Glasgow Coma Scale in traumatic brain injury. Neurosurg Rev 2008, 31:439-444.
8. Sandler S.J., Figaji A.A., Adelson P.D. Clinical applications of biomarkers in pediatric traumatic brain injury. Childs Nerv Syst 2010, 26:205-213.
9. Meric E., Gunduz A., Turedi S., Cakir E., Yandi M. The prognostic value of neuron-specific enolase in head trauma patients. J Emerg Med 2010, 38:297-301.
10. Gradisek P., Osredkar J., Korsic M., Kremzar B. Multiple indicators model of long-term mortality in traumatic brain injury. Brain Inj 2012, 26:1472-1481.
11. Chabok S.Y., Moghadam A.D., Saneei Z., Amlashi F.G., Leili E.K., Amiri Z.M. Neuron-specific enolase and S100BB as outcome predictors in severe diffuse axonal injury. J Trauma Acute Care Surg 2012, 72:1654-1657.
12. Bohmer A.E., Oses J.P., Schmidt A.P., et al. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury. Neurosurgery 2011, 68:1624-1630.
13. Auer J., Berent R., Weber T., et al. Ability of neuron-specific enolase to predict survival to hospital discharge after successful cardiopulmonary resuscitation. CJEM 2006, 8:13-18.
14. Wijdicks E.F., Hijdra A., Young G.B., Bassetti C.L., Wiebe S. Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006, 67:203-210.
15. Stein D.M., Kufera J.A., Lindell A., et al. Association of CSF biomarkers and secondary insults following severe traumatic brain injury. Neurocrit Care 2011, 14:200-207.
16. Stein D.M., Lindell A.L., Murdock K.R., et al. Use of serum biomarkers to predict cerebral hypoxia after severe traumatic brain injury. J Neurotrauma 2012, 29:1140-1149.
17. Einav S., Kaufman N., Algur N., Kark J.D. Modeling serum biomarkers S100 beta and neuron-specific enolase as predictors of outcome after out-of-hospital cardiac arrest: an aid to clinical decision making. J Am Coll Cardiol 2012, 60:304-311.
18. Gonzalez-Garcia S., Gonzalez-Quevedo A., Fernandez-Concepcion O., et al. Short-term prognostic value of serum neuron specific enolase and S100B in acute stroke patients. Clin Biochem 2012, 45:1302-1307.
19. Burghuber O.C., Worofka B., Schernthaner G., et al. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer. Cancer 1990, 65:1386-1390.
20. Niklinski J., Furman M. Clinical tumour markers in lung cancer. Eur J Cancer Prev 1995, 4:129-138.
21. Holdenrieder S., von Pawel J., Dankelmann E., et al. Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer. Clin Cancer Res 2008, 14:7813-7821.
22. Cho W.C. Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer. Biomed Pharmacother 2007, 61:515-519.
23. Riley R.D., Heney D., Jones D.R., et al. A systematic review of molecular and biological tumor markers in neuroblastoma. Clin Cancer Res 2004, 10:4-12.
24. Zandbergen E.G., Hijdra A., Koelman J.H., et al. Prediction of poor outcome within the first 3days of postanoxic coma. Neurology 2006, 66:62-68.
25. Hypoxia after Cardiac Arrest Study Group Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002, 346:549-556.
26. Oddo M., Rossetti A.O. Predicting neurological outcome after cardiac arrest. Curr Opin Crit Care 2011, 17:254-259.
27. Cronberg T., Rundgren M., Westhall E., et al. Neuron-specific enolase correlates with other prognostic markers after cardiac arrest. Neurology 2011, 77:623-630.
28. Samaniego E.A., Persoon S., Wijman C.A. Prognosis after cardiac arrest and hypothermia: a new paradigm. Curr Neurol Neurosci Rep 2011, 11:111-119.
29. Samaniego E.A., Mlynash M., Caulfield A.F., Eyngorn I., Wijman C.A. Sedation confounds outcome prediction in cardiac arrest survivors treated with hypothermia. Neurocrit Care 2011, 15:113-119.
30. Marangos P.J., Campbell I.C., Schmechel D.E., Murphy D.L., Goodwin F.K. Blood platelets contain a neuron-specific enolase subunit. J Neurochem 1980, 34:1254-1258.
31. Ramont L., Thoannes H., Volondat A., Chastang F., Millet M.-C., Maquart F.-X. Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice. Clin Chem Lab Med 2005, 43:1215-1217.
32. Berger R., Richichi R. Derivation and validation of an equation for adjustment of neuron-specific enolase concentrations in hemolyzed serum. Pediatr Crit Care Med 2009, 10:260-263.
33. Verfaillie C.J., Delanghe J.R. Hemolysis correction factor in the measurement of serum neuron-specific enolase. Clin Chem Lab Med 2010, 48:891-892.
34. Tolan N.V., Genes L.I., Subasinghe W., Raththagala M., Spence D.M. Personalized metabolic assessment of erythrocytes using microfluidic delivery to an array of luminescent wells. Anal Chem 2009, 81:3102-3108.
35. Fairbanks V.F., Ziesmer S.C., O'Brien P.C. Methods for measuring plasma hemoglobin in micromolar concentration compared. Clin Chem 1992, 38:132-140.
36. Fugate J.E., Wijdicks E.F., Mandrekar J., et al. Predictors of neurologic outcome in hypothermia after cardiac arrest. Ann Neurol 2010, 68:907-914.
37. Storm C., Nee J., Jorres A., Leithner C., Hasper D., Ploner C. Serial measurement of neuron specific enolase improves prognostication in cardiac arrest patients treated with hypothermia: a prospective study. Scand J Trauma Resusc Emerg Med 2012, 20:6.
38. Steffen I.G., Hasper D., Ploner C.J., et al. Mild therapeutic hypothermia alters neuron specific enolase as an outcome predictor after resuscitation: 97 prospective hypothermia patients compared to 133 historical non-hypothermia patients. Crit Care 2010, 14:R69.